“My key focus is to take Sinclair Research’s preclinical services to the next level in anticipation of our customers’ growing needs,” Brown said. “We have attracted top scientific and operational leadership to strengthen Sinclair’s GLP service offering and are developing strategic partnerships to further expand our portfolio of services available to our sponsors.”
Andy is a result-oriented commercial leader whose diverse background in pre-clinical research and the lab animal industry make him a perfect match for his role at Sinclair. He brings extensive knowledge of and experience in global R&D organizations relative to the development of novel compounds, devices and diagnostic products.
Brown joins Sinclair Research from Envigo where he served in commercial roles for multiple preclinical services including discovery science, toxicology, veterinary services, animal nutrition and research models. For the last two years, he served as vice president of global strategic accounts, leading a global integrated team of global strategic account directors to develop program solutions for the world’s largest pharmaceutical, crop protection and chemical developers. Prior to Envigo, Andy worked at Harlan Laboratories where he held a number of sales and marketing roles before moving into sales management.
“Andy’s preclinical market knowledge and experience in the CRO industry bring significant value to Sinclair and all its customers,” said Guy Bouchard, DVM, president of Sinclair Research Center. “Andy’s proven leadership skills, passion for innovation and industry experience will be invaluable as we continue to grow our business.”
About Sinclair Research
Sinclair Research Center, a preclinical contract research organization (CRO), offers animal efficacy models, IND enabling toxicology services and compliant research capabilities to support biopharmaceutical, animal health and medical device development programs. Sinclair is experienced in all research models and are the undisputed experts in miniature swine. With more than 50 years’ experience, Sinclair has emerged as a leader in diabetes, dermal and animal health research services with streamlined quality systems supporting with VICH and GLP compliant studies and SEND reporting with no backlog.